Folate-targeted liposome encapsulating chitosan/oligonucleotide polyplexes for tumor targeting

AAPS PharmSciTech

Volumn 15, Issue 5, 2014, Pages 1087-1092

  Kang, Ji Hee ^a   Battogtokh, Gantumur ^a   Ko, Young Tag ^a  

^a Gachon University   (South Korea)

Author keywords

chitosan; folate targeting; liposomes; oligonucleotide; tumor targeting

Indexed keywords

CHITOSAN; FOLIC ACID; LIPOSOME; NUCLEIC ACID; OLIGONUCLEOTIDE; POLYETHYLENEIMINE; ANTINEOPLASTIC AGENT; COLLOID;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL FUNCTION; CELL VIABILITY ASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENCAPSULATION; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; LIPID MEMBRANE; MELANOMA CELL; MOLECULAR WEIGHT; NONHUMAN; PH; PROTEIN TARGETING; ROOM TEMPERATURE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; COLLOID; DRUG DELIVERY SYSTEM; DRUG FORMULATION; MELANOMA, EXPERIMENTAL; METABOLISM; MOUSE; PARTICLE SIZE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHITOSAN; COLLOIDS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FOLIC ACID; LIPOSOMES; MELANOMA, EXPERIMENTAL; MICE; OLIGONUCLEOTIDES; PARTICLE SIZE;

EID: 84907875176     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-014-0136-5     Document Type: Article

References (31)

1. Shi N, Pardridge WM. Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A. 2000;97(13):7567-72.
2. Wheeler JJ, Palmer L, Ossanlou M, MacLachlan I, Graham RW, Zhang YP, et al. Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. 1999;6(2):271-81.
3. Stuart DD, Kao GY, Allen TM. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1. Cancer Gene Ther. 2000;7(3):466-75.
4. Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem. 1996;271(14):8481-7.
5. Bandyopadhyay P, Ma X, Stieers CL, Kren BT, Steer CJ. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. J Biol Chem. 1999;274(15):10163-72.
6. Heyes J, Palmer L, Chan K, Giesbrecht C, Jeffs L, MacLachlan I. Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA. Mol Ther. 2007;15(4):713-20.
7. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 1995;92(16):7297-301.
8. Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Genet Med. 2005;7(5):657-63.
9. Kircheis R, Wightman L, Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev. 2001;53(3):341-58.
10. Vinogradov SV, Batrakova EV, Kabanov AV. Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem. 2004;15(1):50-60.
11. Ko YT, Bhattacharya R, Bickel U. Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting. J Control Release. 2009;133(3):230-7.
12. Ko YT, Bickel U. Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique. AAPS PharmSciTech. 2012;13(2):373-8.
13. Jones CH, Chen CK, Ravikrishnan A, Rane S, Pfeifer BA. Overcoming nonviral gene delivery barriers: perspective and future. Mol Pharm. 2013;10(11):4082-98.
14. Florea BI, Meaney C, Junginger HE, Borchard G. Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS PharmSci. 2002;4(3):E12.
15. Fernandes JC, Qiu X, Winnik FM, Benderdour M, Zhang X, Dai K, et al. Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies. Int J Nanomedicine. 2012;7:5833-45.
16. Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. 2010;62(1):12-27.
17. Low PS, Antony AC. Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev. 2004;56(8):1055-8.
18. Stephenson SM, Low PS, Lee RJ. Folate receptor-mediated targeting of liposomal drugs to cancer cells. Methods Enzymol. 2004;387:33-50.
19. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med. 1997;3(8):894-9.
20. Saul JM, Annapragada A, Natarajan JV, Bellamkonda RV. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release. 2003;92(1-2):49-67.
21. Pan XQ, Lee RJ. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model. Anticancer Res. 2005;25(1A):343-6.
22. MacLachlan I, Cullis P, Graham RW. Progress towards a synthetic virus for systemic gene therapy. Curr Opin Mol Ther. 1999;1(2):252-9.
23. Fenske DB, MacLachlan I, Cullis PR. Long-circulating vectors for the systemic delivery of genes. Curr Opin Mol Ther. 2001;3(2):153-8.
24. Wang W, Li W, Ma N, Steinhoff G. Non-viral gene delivery methods. Curr Pharm Biotechnol. 2013;14(1):46-60.
25. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36-48.
26. Huang SL. Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev. 2008;60(10):1167-76.
27. Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 1997;4(9):891-900.
28. Muller K, Nahde T, Fahr A, Muller R, Brusselbach S. Highly efficient transduction of endothelial cells by targeted artificial virus-like particles. Cancer Gene Ther. 2001;8(2):107-17.
29. Buschmann MD, Merzouki A, Lavertu M, Thibault M, Jean M, Darras V. Chitosans for delivery of nucleic acids. Adv Drug Deliv Rev. 2013;65(9):1234-70.
30. Milla P, Dosio F, Cattel L. PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr Drug Metab. 2012;13(1):105-19.
31. Zwicke GL, Mansoori GA, Jeffery CJ. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev. 2012;3:18496.